← All trials
NCT00875368
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2009
- Primary completion
- Dec 1, 2011
- Completion date
- Aug 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 85
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Utrecht UniversityLead sponsor
- Utrecht UniversityOverall official - principal investigator
- Utrecht UniversitySponsor investigator
- Slotervaart HospitalCollaborator
- Rijnstate HospitalCollaborator
- PfizerCollaborator
- Leiden UniversityCollaborator
- Onze Lieve Vrouw HospitalCollaborator
- University of AmsterdamCollaborator
- Erasmus University RotterdamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.